Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001641172-25-003411
Filing Date
2025-04-09
Accepted
2025-04-09 16:15:45
Documents
19
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 formdef14a.htm   iXBRL DEF 14A 586101
2 formdef14a_03.jpg GRAPHIC 105160
3 formdef14a_04.jpg GRAPHIC 108061
4 proxy_001.jpg GRAPHIC 351287
5 proxy_002.jpg GRAPHIC 441994
  Complete submission text file 0001641172-25-003411.txt   3716519

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE abeo-20241231.xsd EX-101.SCH 5447
7 XBRL CALCULATION FILE abeo-20241231_cal.xml EX-101.CAL 896
8 XBRL DEFINITION FILE abeo-20241231_def.xml EX-101.DEF 9278
9 XBRL LABEL FILE abeo-20241231_lab.xml EX-101.LAB 62570
10 XBRL PRESENTATION FILE abeo-20241231_pre.xml EX-101.PRE 45446
21 EXTRACTED XBRL INSTANCE DOCUMENT formdef14a_htm.xml XML 65619
Mailing Address 6555 CARNEGIE AVE, 4TH FLOOR CLEVELAND OH 44103
Business Address 6555 CARNEGIE AVE, 4TH FLOOR CLEVELAND OH 44103 646-813-4701
ABEONA THERAPEUTICS INC. (Filer) CIK: 0000318306 (see all company filings)

EIN.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-15771 | Film No.: 25825388
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)